These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine. Kumar S; Ng B; Howie W Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173 [No Abstract] [Full Text] [Related]
44. Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms. Arango C; Kirkpatrick B; Buchanan RW J Nerv Ment Dis; 2000 Jan; 188(1):50-3. PubMed ID: 10665462 [No Abstract] [Full Text] [Related]
45. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637 [TBL] [Abstract][Full Text] [Related]
46. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. Rodriguez CI; Corcoran C; Simpson HB Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428 [TBL] [Abstract][Full Text] [Related]
47. The pharmacotherapy of moral or religious scrupulosity. Fallon BA; Liebowitz MR; Hollander E; Schneier FR; Campeas RB; Fairbanks J; Papp LA; Hatterer JA; Sandberg D J Clin Psychiatry; 1990 Dec; 51(12):517-21. PubMed ID: 2258366 [TBL] [Abstract][Full Text] [Related]
48. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Hollander E; Stein DJ; DeCaria CM; Saoud JB; Klein DF; Liebowitz MR Biol Psychiatry; 1993 May; 33(10):747-9. PubMed ID: 8353170 [No Abstract] [Full Text] [Related]
49. Management of schizophrenia with obsessive-compulsive features. Hwang MY; Kim SW; Yum SY; Opler LA Psychiatr Clin North Am; 2009 Dec; 32(4):835-51. PubMed ID: 19944887 [TBL] [Abstract][Full Text] [Related]